PacBio collaborates with Radboudumc to explore genetic causes of rare and genetic diseases

FHS
June 19, 2023
5:10 am

PacBio, a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with Radboud University Medical Center (Radboudumc) to explore genetic causes of rare and genetic diseases.

Drugs alone can’t win the war against tuberculosis

Recently, after years of pressure, advocates including author and philanthropist John Green scored victory against Johnson & Johnson over a patent on a key tuberculosis

August 7, 2023

Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis

Researchers explored using Erigeron breviscapus (EB) as a treatment for osteoarthritis (OA).

April 4, 2024

Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.